Literature DB >> 8304494

Stretch preconditions canine myocardium.

M Ovize1, R A Kloner, K Przyklenk.   

Abstract

Preconditioning is believed to be directly triggered by brief ischemia-reperfusion. However, brief ischemia results in transient dilation (or stretching) of the heart. We therefore sought to determine whether stretch per se, induced by rapid volume overload instead of brief coronary occlusion, could precondition the heart via stretch-activated ion channels. Forty-two anesthetized dogs underwent 1 h of coronary artery occlusion followed by 4.5 h of reperfusion. Before this, each dog underwent either no intervention (control) or acute volume overload. In three additional groups, Gd3+, a potent blocker of stretch-activated channels was injected as a bolus into the left atrium of each dog at the onset of the treatment period. Then the dogs underwent either acute volume overload, a 5-min episode of coronary occlusion followed by 10 min of reperfusion, or no intervention. Myocardial stretch significantly reduced infarct size after a subsequent 60-min ischemic insult. Protection afforded by stretch was completely prevented by Gd3+. Reduction in infarct size afforded by ischemic preconditioning was partially reversed by Gd3+. Gd3+ per se did not, however, alter the extent of necrosis. The present study suggests that myocardial stretch per se can precondition the canine heart, probably by activation of stretch-activated ion channels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8304494     DOI: 10.1152/ajpheart.1994.266.1.H137

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

Review 1.  Angiogenic signal during cardiac repair.

Authors:  Nilanjana Maulik
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

Review 2.  [Myocardial preconditioning with volatile anesthetics. General anesthesia as protective intervention?].

Authors:  H Buchinger; U Grundmann; S Ziegeler
Journal:  Anaesthesist       Date:  2005-09       Impact factor: 1.041

Review 3.  An alternative perspective on ischemic preconditioning derived from mathematical modeling.

Authors:  P Whittaker
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

Review 4.  Cardioprotection by organs in stress or distress.

Authors:  P D Verdouw; B C Gho; D J Duncker
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

5.  Protection from preconditioning can be reinstated at various reperfusion intervals.

Authors:  E K Iliodromitis; C Papadopoulos; I A Paraskevaidis; Z S Kyriakides; C Flessa; D T Kremastinos
Journal:  Cardiovasc Drugs Ther       Date:  1996-07       Impact factor: 3.727

6.  Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning.

Authors:  A M Vogt; P Htun; M Arras; T Podzuweit; W Schaper
Journal:  Basic Res Cardiol       Date:  1996 Sep-Oct       Impact factor: 17.165

7.  Mechanical Stretch-Induced Protection against Myocardial Ischemia-Reperfusion Injury Involves AMP-Activated Protein Kinase.

Authors:  Jia Hao; Hun-Sik Kim; Woong Choi; Tae Sun Ha; Hee-Yul Ahn; Chan-Hyung Kim
Journal:  Korean J Physiol Pharmacol       Date:  2010-02-28       Impact factor: 2.016

8.  Long-term protection and mechanism of pacing-induced postconditioning in the heart.

Authors:  Fawzi A Babiker; Ilka Lorenzen-Schmidt; Eric Mokelke; Ward Y Vanagt; Tammo Delhaas; Johannes Waltenberger; Jack P Cleutjens; Frits W Prinzen
Journal:  Basic Res Cardiol       Date:  2010-03-25       Impact factor: 17.165

Review 9.  Non-ischemic myocardial preconditioning.

Authors:  R Domenech; P Macho
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

10.  Reductions in mitochondrial O(2) consumption and preservation of high-energy phosphate levels after simulated ischemia in chronic hibernating myocardium.

Authors:  Qingsong Hu; Gen Suzuki; Rebeccah F Young; Brian J Page; James A Fallavollita; John M Canty
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-04-24       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.